Supriya Lifescience Reports Q1 2026 Unaudited Financial Results; Revenue Reaches 1,897.47 R Million
Supriya Lifescience Limited announced its unaudited financial results for the quarter ended June 30, 2026. The company's Board of Directors reviewed and approved these outcomes at a meeting held on August 13, 2026.The Financial Statements reflect operational updates, including the status of material dispatched, which was intercepted and detained by Customs as of June 30, 2026. Despite this event, the transaction was recorded as a sale in the company's books. The unaudited results were reviewed by the Audit Committee and subsequently approved by the Board of Directors.
The financial performance metrics for the quarter ended June 30, 2026, compared across several periods:
| Particulars | Quarter ended 30-06-2026 (Unaudited) | Quarter ended 31-03-2026 (Audited) | Quarter ended 30-06-2025 (Unaudited) | Year ended 31-03-2026 (Audited) |
|---|---|---|---|---|
| Revenue from Operations | 1,897.47 | 2,765.28 | 1,450.74 | 8,278.75 |
| Other Income | 26.48 | 34.78 | 26.74 | 114.87 |
| Total Income | 1,923.95 | 2,800.00 | 1,477.48 | 8,393.62 |
| Cost of Materials Consumed | 1,094.00 | 833.61 | 437.76 | 2,651.18 |
| Change in inventories of finished goods, work in progress & stock in trade | (530.15) | 219.66 | (120.04) | (110.89) |
| Employee benefit expenses | 284.90 | 248.17 | 226.88 | 966.80 |
| Finance Cost | 3.74 | 4.68 | 5.12 | 18.89 |
| Depreciation & amortisation expense | 89.40 | 84.98 | 64.51 | 284.09 |
| Other expenditure | 574.14 | 487.67 | 389.13 | 1,831.18 |
| Total Expenses | 1,516.03 | 1,117.87 | 1,003.36 | 5,641.25 |
| Profit/(loss) before Exceptional Items & Tax | 407.92 | 921.29 | 474.12 | 2,752.37 |
The company reported total income of 1,923.95 R Million for the quarter ended June 30, 2026. The unaudited results were prepared according to Indian Accounting Standard (Ind AS) as prescribed under Section 133 of the Companies Act, 2013.
The financial statements also included earnings per equity share, with both basic and diluted EPS for continuing operations standing at 240.43 R Million.
SUPRIYA Stock Price Movement
Supriya Lifescience Limited shares today slipped by 2.17% to settle at ₹813.50, continuing a downward trend throughout the session. The equity traded volumes of 520,083 shares during the day's trading activity.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.